Drug Developement/Delivery
- FDA Approves SYFOVRE™ – First Treatment for Geographic Atrophy
- Nanobodies - Current Status and Prospects
- Targeted Therapies for Multiple Myeloma (MM)
- IL-6 Unveiled: From Inflammation to Breakthrough Therapeutics
- 10 Potential Blockbuster Drug Approvals in 2023
- Antibody–Oligonucleotide Conjugates (AOCs) in Clinical Trials
- Alzheimer's Disease Drug Development: Aducanumab, Lecanemab & Donanemab
- Emerging Antibody–siRNA Conjugates (ARC)
- Recent Advances In Hematology 2022: ADCs, Bispecific Antibodies, CAR-T Cells…
- Emerging Multiple Myeloma Therapies: mAbs, ADCs, CAR-T Cells & Bispecific Antibodies